Acute suicidal behavior following ayahuasca ingestion in a clinical trial setting: a case report.
José Augusto S. Reis, Giordano N. Rossi, Anna Beatriz V. Zacharias, Jaime E. C. Hallak, Rafael G. Dos Santos
Braz J Psychiatry September 29, 2025 DOI: 10.47626/1516-4446-2025-4354 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA case report describes an instance of acute suicidal behavior that occurred after a participant ingested ayahuasca in a clinical trial setting. The report details the circumstances and clinical presentation of this adverse event, highlighting a potential risk associated with ayahuasca use even within a controlled research environment. The authors suggest that such reactions, though rare, warrant careful screening and monitoring of participants in psychedelic research.
Study at a glance
| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A participant in a clinical trial who ingested ayahuasca |
| Intervention | Ayahuasca |
| Key finding | Acute suicidal behavior occurred after ayahuasca ingestion in a clinical trial setting. |
Abstract
Acute suicidal behavior following ayahuasca ingestion in a clinical trial setting: a case report.